Skip to main content
颖泰生物 logo

颖泰生物 — Investor Relations & Filings

Ticker · 920819 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 419 across all filing types
Latest filing 2024-08-18 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920819

About 颖泰生物

https://www.nutrichem.cn/

Nutrichem Company Limited focuses on the research, development, production, and distribution of agrochemical active ingredients and formulations. The product portfolio includes a diverse array of herbicides, fungicides, and insecticides tailored for global agricultural applications. The company provides comprehensive contract development and manufacturing organization (CDMO) services, supporting international partners through the entire product lifecycle from synthesis to commercial-scale production. With a strong emphasis on research and development, Nutrichem utilizes advanced chemical synthesis technologies and process optimization to ensure high-quality output and operational efficiency. Its integrated supply chain and large-scale manufacturing infrastructure enable the delivery of customized crop protection solutions to meet the evolving needs of the global agricultural sector.

Recent filings

Filing Released Lang Actions
第四届监事会第五次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Beijing Yingtai Jiahe Biotechnology Co., Ltd. It details the meeting date, attendance, and the approval of the 2024 semi-annual report and a special report on the use of raised funds. However, the actual semi-annual report and the special report are referenced as being published separately on the Beijing Stock Exchange information disclosure platform, with specific announcement numbers given. The document itself is short (1104 characters) and serves as a formal announcement of the Supervisory Board's meeting resolutions rather than containing the full financial report or detailed financial data. According to the 'Menu vs Meal' rule, this is an announcement of a report, not the report itself. Therefore, the appropriate classification is Regulatory Filings (RNS), as it is a formal regulatory announcement that does not contain substantive financial data or the full report.
2024-08-18 Chinese
关于新增2024年度日常性关联交易的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the addition of expected daily related-party transactions for the year 2024 by Beijing Yingtai Jiahe Biotechnology Co., Ltd. It details the nature, amounts, and counterparties of these related-party transactions, along with board meeting approvals and compliance statements. The document is relatively short (3935 characters) and focuses on disclosure of related-party transactions rather than financial results or comprehensive reports. It does not contain financial statements or detailed financial analysis. This type of disclosure fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2024-08-18 Chinese
第四届董事会第六次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the sixth meeting of the fourth board of directors of Beijing Yingtai Jiahe Biotechnology Co., Ltd. It details the meeting's attendance, procedures, and voting results on several agenda items, including approval of the 2024 semi-annual report and related documents. However, the actual semi-annual report and other detailed reports are referenced as being published separately on the Beijing Stock Exchange information disclosure platform, with specific announcement numbers provided. The document itself does not contain the financial data or substantive analysis of the semi-annual report but serves as a board meeting resolution announcement. This fits the category of Board/Management Information (MANG), which covers announcements of board decisions and management matters. The document length is short (1684 characters), and it does not contain the full report, so it is not an Interim/Quarterly Report (IR) or Annual Report (10-K).
2024-08-18 Chinese
关于2024年半年度募集资金存放与实际使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is a detailed report on the management and actual use of funds raised by Beijing Yingtai Jiahe Biotechnology Co., Ltd. It includes specifics on the amount raised, usage, balance, and compliance with regulatory requirements. The report references regulatory guidelines from the China Securities Regulatory Commission and the Beijing Stock Exchange, and it provides a comprehensive breakdown of fundraising activities and fund usage up to June 30, 2024. The document is titled as a "专项报告" (special report) on fundraising funds storage and actual use, which aligns with a specialized report on capital raising and fund usage rather than a general annual or interim financial report. It is not a brief announcement but a substantive report with financial figures and compliance details. This fits the definition of a Capital/Financing Update (CAP) as it focuses on fundraising and capital management activities.
2024-08-18 Chinese
2024年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive report covering a six-month period from January 1, 2024, to June 30, 2024, as indicated in the definitions section. It includes detailed financial data such as income, profit, assets, liabilities, cash flow, and segment analysis. It also contains management discussion on business operations, industry conditions, risk factors, and social responsibility. The document explicitly states it is a "半年度报告" which translates to "half-year report" or interim report. The length of the document (15,000 characters) and the presence of substantive financial statements and analysis confirm it is a full interim/quarterly report rather than a brief announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H1 2024
2024-08-18 Chinese
2024年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a '半年度报告摘要' which translates to 'Half-Year Report Summary' and contains detailed financial data such as total assets, net profit, earnings per share, and shareholder information for a half-year period. It includes sections on company business, financial data, shareholding structure, and important matters during the reporting period. The document explicitly states it is an unaudited half-year report and provides comprehensive financial and operational information for the period. This matches the characteristics of an Interim / Quarterly Report (IR), which is a comprehensive financial report for a period shorter than a full fiscal year containing substantive financial data and analysis. The document length (5088 characters) and content confirm it is the report itself, not just an announcement or summary. Therefore, the correct classification is IR with high confidence. H1 2024
2024-08-18 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.